Close Menu
Home » Guardant Health Q4 Revenues Up 64 Percent

Guardant Health Q4 Revenues Up 64 Percent

Mar 12, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Guardant Health's stock surged in Wednesday morning trading after the company reported that its fourth quarter revenues rose 64 percent year over year, driven by a 98 percent increase in revenues from its precision oncology business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Not Going for the Move

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

And Overturned

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

Food for Billions More

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

Nature Examines New RNA Editing Approach, Musa Balbisiana Genome, More

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.

What's Popular?

In Business News

  1. Seer Raises $17.5 M in Series C Financing Round

  2. Broad Institute, MilliporeSigma Create CRISPR IP License Framework

  3. European Patent Office Revokes Second Pacific Biosciences Patent

  4. Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent

  5. Abbott Q2 Diagnostics Revenues Rise 2 Percent, MDx Revenues Down 12 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.